Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More
Xconomy
MARCH 30, 2018
in the first quarter was up 44 percent compared to the same period a year ago, according to data compiled by consulting and accounting firm EY. The strength of the IPO market is notable because the first quarter is typically the slowest time of the year for companies to go public, EY told Xconomy.
52 
Let's personalize your content